Anti-Bet v 1 monoclonal antibodies
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-Bet v 1 monoclonal antibodies, covering 2022-10-27 to 2022-10-27. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis [Phase 3]